510(K) Submission - A Comprehensive and an Updated Overview
| Date: | 19-Jan-17 to 19-Jan-17 |
| Location: | GRC Training Solutions / United States |
| Category: | Education Conferences & Trade Fairs |
Why should you attend:
The section [510(k)] of the Federal Food, Drug, and Cosmetic Act (FD&C Act or the Act) prescribes the premarket notification requirements. The premarket notification [510(k)] is the most common pathway to market for medical devices including in vitro diagnostic medical devices (IVDs). The 510(k) premarket submission is made to US FDA to demonstrate that the subject device (to be marketed) is substantially equivalent (as least as safe and effective) to a legally marketed device(s) (predicate device) as described in 21 CFR 807.92(a)(3). In other words, firms must demonstrate that a proposed product is substantially equivalent to another, a legally marketed medical device that is also lower-risk and is not subject to premarket approval (PMA). Over time, the 510(k) program has significantly evolved, affecting the 510(k) decision-making process.
To expedite the process of bringing a product to market through the 510(k) program, it is imperative that the medical device manufacturers understand how to expedite the FDA review process leading to a prompt clearance in view of recent trends and customized strategy for a successful clearance.
This presentation is intended to demonstrate how to improve submission quality, which will subsequently prevent avoidable delays and reduce review times.
In this webinar, we will discuss:
Statute(s) and Regulations
Definitions
Medical Device Classification
510(k) Process
Selecting Predicate Device(s)
De Novo Process – Practical Advice
How To Demonstrate Substantial Equivalence
510(K) Contents And Format
Addressing Technical And Regulatory Requirements.
510(k) Submission Quality For A Product-Be Aware.
Responding to FDA’s Request Of Additional Information.
Resolving Different Opinions Between The Submitter And FDA Reviewer(S).
For More Details:https://www.grcts.com/GRC-90075.
Email:david@grcts.com | Tel:+1-248-233-2049 | Web:www.grcts.com
The section [510(k)] of the Federal Food, Drug, and Cosmetic Act (FD&C Act or the Act) prescribes the premarket notification requirements. The premarket notification [510(k)] is the most common pathway to market for medical devices including in vitro diagnostic medical devices (IVDs). The 510(k) premarket submission is made to US FDA to demonstrate that the subject device (to be marketed) is substantially equivalent (as least as safe and effective) to a legally marketed device(s) (predicate device) as described in 21 CFR 807.92(a)(3). In other words, firms must demonstrate that a proposed product is substantially equivalent to another, a legally marketed medical device that is also lower-risk and is not subject to premarket approval (PMA). Over time, the 510(k) program has significantly evolved, affecting the 510(k) decision-making process.
To expedite the process of bringing a product to market through the 510(k) program, it is imperative that the medical device manufacturers understand how to expedite the FDA review process leading to a prompt clearance in view of recent trends and customized strategy for a successful clearance.
This presentation is intended to demonstrate how to improve submission quality, which will subsequently prevent avoidable delays and reduce review times.
In this webinar, we will discuss:
Statute(s) and Regulations
Definitions
Medical Device Classification
510(k) Process
Selecting Predicate Device(s)
De Novo Process – Practical Advice
How To Demonstrate Substantial Equivalence
510(K) Contents And Format
Addressing Technical And Regulatory Requirements.
510(k) Submission Quality For A Product-Be Aware.
Responding to FDA’s Request Of Additional Information.
Resolving Different Opinions Between The Submitter And FDA Reviewer(S).
For More Details:https://www.grcts.com/GRC-90075.
Email:david@grcts.com | Tel:+1-248-233-2049 | Web:www.grcts.com
Exhibitors
Dr. David Lim
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
